Evidence map›Paper›PMID 42890907›Full record

ArticleJournal of medical physics

Prabhat Krishna Sharma, Saral Kumar Gupta, Devesh Gupta

Abstract read
In one paragraph

Article in Journal of medical physics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Prabhat Krishna SharmaDepartment of Physical Sciences, Banasthali Vidyapith, Tonk, Rajasthan, India.
Saral Kumar GuptaDepartment of Physical Sciences, Banasthali Vidyapith, Tonk, Rajasthan, India.
Devesh GuptaDepartment of Radiological Physics, Dr. S. N. Medical College, Regional Cancer Institute, Jodhpur, Rajasthan, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: High-dose-rate (HDR) brachytherapy (BT) is an important part of the treatment of cervical cancer. Although there have been advances in three-dimensional image-guided treatment planning systems (TPSs), uncertainties in applicator positioning and anatomical variations can produce discrepancies in planned and delivered doses. This study aimed to evaluate the clinical feasibility and reliability of dysprosium-doped calcium sulfate (CaSO Materials and Methods: For calibration, the CaSO Results: In-depth phantom measurements demonstrated that, for the same delivered dose, the response of CaSO Conclusion: The results confirm that with proper calibration, CaSO

Indexed as

Dose verificationimage-guided brachytherapyorgan-at-risk dosimetrythermoluminescent dosimetrytreatment planning systemuncertainty analysis

Identifiers

PMID42890907
PMCPMC13675027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.